Literature DB >> 1409351

Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations.

J Brange1, L Langkjaer, S Havelund, A Vølund.   

Abstract

Hydrolysis of insulin has been studied during storage of various preparations at different temperatures. Insulin deteriorates rapidly in acid solutions due to extensive deamidation at residue AsnA21. In neutral formulations deamidation takes place at residue AsnB3 at a substantially reduced rate under formation of a mixture of isoAsp and Asp derivatives. The rate of hydrolysis at B3 is independent of the strength of the preparation, and in most cases the species of insulin, but varies with storage temperature and formulation. Total transformation at B3 is considerably reduced when insulin is in the crystalline as compared to the amorphous or soluble state, indicating that formation of the rate-limiting cyclic imide decreases when the flexibility of the tertiary structure is reduced. Neutral solutions containing phenol showed reduced deamidation probably because of a stabilizing effect of phenol on the tertiary structure (alpha-helix formation) around the deamidating residue, resulting in a reduced probability for formation of the intermediate imide. The ratio of isoAsp/Asp derivative was independent of time and temperature, suggesting a pathway involving only intermediate imide formation, without any direct side-chain hydrolysis. However, increasing formation of Asp relative to isoAsp derivative was observed with decreasing flexibility of the insulin three-dimensional structure in the formulation. In certain crystalline suspensions a cleavage of the peptide bond A8-A9 was observed. Formation of this split product is species dependent: bovine greater than porcine greater than human insulin. The hydrolytic cleavage of the peptide backbone takes place only in preparations containing rhombohedral crystals in addition to free zinc ions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409351     DOI: 10.1023/a:1015835017916

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer.

Authors:  U Derewenda; Z Derewenda; E J Dodson; G G Dodson; C D Reynolds; G D Smith; C Sparks; D Swenson
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

2.  Sequence and structure determinants of the nonenzymatic deamidation of asparagine and glutamine residues in proteins.

Authors:  H T Wright
Journal:  Protein Eng       Date:  1991-02

3.  Tertiary structure is a principal determinant to protein deamidation.

Authors:  A A Kossiakoff
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

4.  Stability of insulin preparations.

Authors:  M Pingel; A Volund
Journal:  Diabetes       Date:  1972-07       Impact factor: 9.461

5.  Effect of storage temperature on stability of commercial insulin preparations.

Authors:  W O Storvick; H J Henry
Journal:  Diabetes       Date:  1968-08       Impact factor: 9.461

6.  The structure of 2Zn pig insulin crystals at 1.5 A resolution.

Authors:  E N Baker; T L Blundell; J F Cutfield; S M Cutfield; E J Dodson; G G Dodson; D M Hodgkin; R E Hubbard; N W Isaacs; C D Reynolds
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1988-07-06       Impact factor: 6.237

7.  Phenol-promoted structural transformation of insulin in solution.

Authors:  A Wollmer; B Rannefeld; B R Johansen; K R Hejnaes; P Balschmidt; F B Hansen
Journal:  Biol Chem Hoppe Seyler       Date:  1987-08

8.  Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone.

Authors:  N P Bhatt; K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

9.  Deamidation of the asparaginyl-glycyl sequence.

Authors:  Y C Meinwald; E R Stimson; H A Scheraga
Journal:  Int J Pept Protein Res       Date:  1986-07

10.  Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography.

Authors:  R Gregory; S Edwards; N A Yateman
Journal:  Diabetes Care       Date:  1991-01       Impact factor: 19.112

View more
  26 in total

1.  Chemical modification of insulin in amyloid fibrils.

Authors:  Melanie R Nilsson; Christopher M Dobson
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

2.  Chemical stability of insulin. 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations.

Authors:  J Brange; S Havelund; P Hougaard
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

3.  Insulin fibrillation and protein design: topological resistance of single-chain analogs to thermal degradation with application to a pump reservoir.

Authors:  Nelson B Phillips; Jonathan Whittaker; Faramarz Ismail-Beigi; Michael A Weiss
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

4.  Self-association properties of monomeric insulin analogs under formulation conditions.

Authors:  J P Richards; M P Stickelmeyer; D B Flora; R E Chance; B H Frank; M R DeFelippis
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

5.  The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form.

Authors:  M J Pikal; D R Rigsbee
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

6.  Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics.

Authors:  Maryam Ahmadi; Christine J Bryson; Edward A Cloake; Katie Welch; Vasco Filipe; Stefan Romeijn; Andrea Hawe; Wim Jiskoot; Matthew P Baker; Mark H Fogg
Journal:  Pharm Res       Date:  2015-04       Impact factor: 4.200

Review 7.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

8.  Chemical and alpha-chymotrypsin-mediated proteolytic degradation of insulin in bile salt-unsaturated fatty acid mixed micellar systems.

Authors:  Y Li; Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

9.  Prediction of protein deamidation rates from primary and three-dimensional structure.

Authors:  N E Robinson; A B Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

10.  Major degradation products of basic fibroblast growth factor: detection of succinimide and iso-aspartate in place of aspartate.

Authors:  Z Shahrokh; G Eberlein; D Buckley; M V Paranandi; D W Aswad; P Stratton; R Mischak; Y J Wang
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.